Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
46.2M
-
Shares change
-
-1.28M
-
Total reported value, excl. options
-
$430M
-
Value change
-
-$27.6M
-
Put/Call ratio
-
0.09
-
Number of buys
-
62
-
Number of sells
-
-51
-
Price
-
$9.30
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q1 2015
146 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q1 2015.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.2M shares
of 58.9M outstanding shares and own 78.48% of the company stock.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (4.21M shares), DEERFIELD MANAGEMENT CO (4.13M shares), PAULSON & CO. INC. (3.95M shares), Palo Alto Investors, LLC (3.8M shares), FMR LLC (2.96M shares), STATE STREET CORP (2.69M shares), ARMISTICE CAPITAL, LLC (2.28M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.93M shares), BAKER BROS. ADVISORS LP (1.75M shares), and MILLENNIUM MANAGEMENT LLC (1.6M shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.